Related Experiment Video
Updated: Aug 29, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through
Geoffrey B Johnson1, Gregory J Brunn, Jeffrey L Platt
1Department of Immunology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Abstract:
Systemic inflammatory response syndrome (SIRS) is typically associated with trauma, surgery, or acute pancreatitis. SIRS resembles sepsis, triggered by exogenous macromolecules such as LPS acting on Toll-like receptors. What triggers SIRS in the absence of infection, however, is unknown. In this study, we report that a SIRS-like response can be induced in mice by administration of soluble heparan sulfate, a glycosaminoglycan associated with nucleated cells and extracellular matrices, and by elastase, which cleaves and releases heparan sulfate proteoglycans. The ability of heparan sulfate and elastase to induce SIRS depends on functional Toll-like receptor 4, because mutant mice lacking that receptor or its function do not respond. These results provide a molecular explanation for the initiation of SIRS.
Related Concept Videos
The JAK-STAT Signaling Pathway
Acute Inflammation III: Local and Systemic Effects
Acute Inflammation I: Inflammatory Response
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Regulation of the Unfolded Protein Response
Inflammatory Bowel Disease III: Crohn's Disease
